A Comprehensive Review on Transdermal Delivery of Nanosponges
DOI:
https://doi.org/10.22270/ajprd.v11i4.1298Keywords:
Nanosponges, Transdermal, Nanotechnology, Targeting drug delivery systemAbstract
The field of innovative medication delivery has greatly benefited from nanotechnology and miniaturisation, which have also transformed the potential in the current healthcare industry. The design of nano-scale drug carriers using various nanotechnology-based approaches for the delivery of lipophilic drug molecules is the current trend in novel drug delivery-based research. Nanotechnology and miniaturisation, which have also changed the possibilities in the contemporary healthcare business, have tremendously helped the field of inventive medicine distribution. Targeting medication distribution in a regulated manner is made possible in large part by NSs. The use of NSs, its preparation, and assessment have all been covered in this review paper. The healthcare industry is seeing encouraging results from a variety of nanosponges formulations, including parenteral, topical, oral, and inhalation, which offer enormous promise for future development and study.
Downloads
Download data is not yet available.
References
1. Emeje MO, Obidike IC, Akpabio EI, et al. Nanotechnology in drug delivery. Recent Advances in Novel Drug Carrier Systems 2012; 69-106.
2. Bamrungsap S, Zhao Z, Chen T, et al. Nanotechnology in therapeutics: a focus on nanoparticles as a drug delivery system. Nanomedicine 2012;7(8):1253-71.
3. Farooq MA, Aquib M, Farooq A, et al. Recent progress in nanotechnology based novel drug delivery systems in designing of cisplatin for cancer therapy: an overview. Artificial Cells, Nanomedicine, and Biotechnology 2019;47(1):1674-92.
4. Koo OM, Rubinstein I, Onyuksel H. Role of nanotechnology in targeted drug delivery and imaging: a concise review. Nanomedicine: Nanotechnology, Biology and Medicine 2005;1(3):193-212.
5. Ravichandran R. Nanotechnology-based drug delivery systems. Nano Biotechnology 2009;5(1-4):17-33.
6. Marcato PD, Durán N. New aspects of nano pharmaceutical delivery systems. Journal of Nanoscience and Nanotechnology 2008;8(5):2216-29.
7. Parhi P, Mohanty C, Sahoo SK. Nanotechnology-based combinational drug delivery: an emerging approach for cancer therapy. Drug Discovery Today 2012;17(17-18): 1044-52.
8. Naga S., and Sravanthi L., “Nanosponges: A Versatile Drug Delivery System.” International Journal of Research in Pharmacy and Life Science, 2013; 4(8): 2920-2925.
9. Waghmare SG, Nikhade RR, Satish D, et al. Nanosponges: a novel approach for controlled release drug delivery system. International Journal of Pharmacy and Pharmaceutical Research. 2017;9(3):101-11.
10. Nilesh J., Ruchi J., Navneet T, Brham Prakash G., Deepak Kumar J., Nanotechnology: A Safe and Effective Drug Delivery Systems, Asian Journal of Pharmaceutical and Clinical Research, 2010 vol.3 issue 3 ,159-165.
11. Nacht S, Kantz M.; (1992) The microsponge: a novel topical programmable delivery system, In: Topical Drug Delivery Systems, David W.O and Anfon H.A (ED), 42.
12. Delattre L., Delneuville I., Biopharmaceutical aspects of the formulation of dermatological vehicles. J Eur Acad Derm Vener, 1995, 5: S70.
13. http://Sciencematters, Unimelb.edu.au/ 2011/05/nanosponges for targeted- cancer-treatment/visited on 12/10/2011.
14. Kaur G., Agrawal G., “Nanosponges: New Colloidal Drug Delivery System for Topical Delivery,”, 2015; 5(1): 53-57.
15. Kamal S., SarabjeetS., Ajay A., Sanju N., “Transdermal Gel: An Alternative Vehicle for Drug Delivery.” International Journal of Pharmaceutical Chemicals and Biological Science, 2013; 3(3): 495-503.
16. Behera A., Barik B., “Formulation and Evaluation of Isoniazide Loaded–Ʃ Poly caprolactone Nanoparticle.” Journal of Pharmacy Research.
17. 17.Eki S, Lei T, Jingquan L, Zhongfan J, Cyrille B, Thomas PD. Biodegradable star polymers functionalized with cyclodextrin inclusion complexes. Biomacromolecule 2009; 10:2699-707.
18. Prathima, S., Sreeja K. Formulation and Evaluation of Voriconazole Loaded Nanosponges for Oral and Topical Delivery. Int. J. Drug Dev. & Res., 2013; 5(1): 55-69.
19. Jyoti Pandey, Amandeep Singh. Formulation and Evaluation of Nanosponge Based Controlled Release Topical Gel Preparation of Ketoconazole. IJPPR., 2018;12(3).
20. Quarat-ul-ainshoaib, Nasir Abbas, Muhammad Irfan, Amjad Hussain, Muhammad Sohail Arshad, Syed Zajif Hussain, Sumera Latif, Nadeem Irfan Bukhari. Tropical Journal of Pharmaceutical Research., 2018;17(8):1465-1474.
21. P., Suresh Kumar, N., Hematheerthani, J., VijayaRatna, V., Saikishore. Preparation and Evaluation of Clotrimazole Loaded Nanosponges Containing Vaginal Gels. American journal of pharmacy and health research. American Journal of Pharmacy and Health Research., 2015; 3(7).
22. Swarupa Arvapally, M., Harini, G., Harshitha, A., Arunkumar. American Journal of Pharmtech Research. 2017; 7(3):2249-3387.
23. Nasir Abbas, Amjad Hussain, Muhammad Ahsan Hafiz, Kausar Perveen. British Journal of Pharmacy.,2017; 2(2):41-42.
24. Renuka Sharma, Roderick, B., Walker, Kamla Pathak. Evaluation of Kinetics and Mechanism of Drug Release from Econazole nitrate Nanosponge Loaded Carbopol Hydrogel. Ind J Pham Edu Res., 2011;45(1):25-31.
25. Shankar, S., Vavia, PR., Francesco T, Satyen T. Formulation of Betacyclodextrin based nanosponges of Itraconazole. J Incl Phenom Macrocycl Chem.,2007; 57(1):89-94.
26. Prathima, S., Sreeja K. Formulation and Evaluation of Voriconazole Loaded Nanosponges for Oral and Topical Delivery. Int. J. Drug Dev. & Res., 2013; 5(1): 55-69.
27. P., Suresh Kumar, N., Hematheerthani, J., VijayaRatna, V., Saikishore. Preparation and Evaluation of Clotrimazole Loaded Nanosponges Containing Vaginal Gels. American journal of pharmacy and health research. American Journal of Pharmacy and Health Research., 2015; 3(7).
28. Kumar, PS., Hematheerthani, N., VijayaRatna, J., Saikishore, V. Design and characterization of Miconazole nitrate loaded nanosponges containing vaginal gels. Int J Pharm Ana Res., 2016; 5(3):410-417.
29. Jyoti Pandey, Amandeep Singh. Formulation and Evaluation of Nanosponge Based Controlled Release Topical Gel Preparation of Ketoconazole. IJPPR., 2018;12(3).
30. Nasir Abbas, Amjad Hussain, Muhammad Ahsan Hafiz, Kausar Perveen. British Journal of Pharmacy., 2017; 2(2):41-42.
31. William, K., Benjamin, S., Eva, H. Synthesis and Characterization of Nanosponges for Drug Delivery and Cancer Treatment. Vanderbilt Education., 2011; 20(21).
32. Lala, R., Thorat, A., Gargote, C. Current trends in ß- cyclodextrin based drug delivery systems. Int J Res Ayur Pharm; 2011; 2(5): 1520-1526.
33. Subhash Chandra Bose Penjuri, Nagaraju Ravouru, Saritha Damineni, Sai Lakshmi Bns, Srikanth Reddy Poreddy. Formulation and Evaluation of Lansoprazole Loaded Nanosponges. Turk J Pharm Sci., 2016; 13(3): 304-310.
34. Torne, SJ., Ansari, KA., Vavia, PR., Trotta, F., Cavalli, R. Enhanced oral Paclitaxel bioavailability after administration of Paclitaxel loaded nanosponges. Drug Delivery., 2010; 17(6):419- 425.
35. Nanosponges; a boon to the targeted drug delivery system from SlideShare.
36. Patel, SB., Patel, HJ., Seth, AK. Nanosponge Drug Delivery System: An Overview. Journal of Global Pharma Tech., 2010;2(8):1- 9.
37. Anjali Kumar, Sheri, P.S., M.A., Kuriachan. Formulation and Evaluation of Antifungal Nanosponge Loaded Hydrogel for Topical Delivery. IJPPR., 2018;3(1).
38. Swaminathan, S., Vavia, P.R., Trotta. F: Formulation of beta cyclodextrins based nanosponges of itraconazole. J InclPhenom Macro Chem., 2012;57:89-94.
39. Nacht, S., Kantz, M. The Microsponge: A Novel Topical Programmable Delivery System In: Topical Drug Delivery Systems. New York: Marcel., 1992;42:299-325.
40. Cavalli, R., Ansari, K.A., Vavia, P.R. Nanosponges formulations as oxygen delivery systems. International journal of pharmaceutics.,2010;402:254-247.
41. Shewarts, D., Sofia, S., Friess, W. Integrity and stability studies of precipitated rhBMP-2 microparticles with a focus on ATR-FTIR measurements. Eur J Pharm Biopharm., 2006;63:241-248.
42. Gerges. et al. In vitro release modulation and conformational stabilization of a model protein using swellable polyamidoamine nanosponges of β-cyclodextrin. The Journal of Inclusion Phenomena and Macrocyclic Chemistry., 2010; 68: 183-191.
43. Khalid, AA., Pradeep, RV., Francesco, T., Roberta, C. Cyclodextrin-based nanosponges for delivery of Resveratrol: In Vitro characterisation, stability, cytotoxicity and permeation Study. Pharm Sci Tech., 2011; 12(1): 279-286.
2. Bamrungsap S, Zhao Z, Chen T, et al. Nanotechnology in therapeutics: a focus on nanoparticles as a drug delivery system. Nanomedicine 2012;7(8):1253-71.
3. Farooq MA, Aquib M, Farooq A, et al. Recent progress in nanotechnology based novel drug delivery systems in designing of cisplatin for cancer therapy: an overview. Artificial Cells, Nanomedicine, and Biotechnology 2019;47(1):1674-92.
4. Koo OM, Rubinstein I, Onyuksel H. Role of nanotechnology in targeted drug delivery and imaging: a concise review. Nanomedicine: Nanotechnology, Biology and Medicine 2005;1(3):193-212.
5. Ravichandran R. Nanotechnology-based drug delivery systems. Nano Biotechnology 2009;5(1-4):17-33.
6. Marcato PD, Durán N. New aspects of nano pharmaceutical delivery systems. Journal of Nanoscience and Nanotechnology 2008;8(5):2216-29.
7. Parhi P, Mohanty C, Sahoo SK. Nanotechnology-based combinational drug delivery: an emerging approach for cancer therapy. Drug Discovery Today 2012;17(17-18): 1044-52.
8. Naga S., and Sravanthi L., “Nanosponges: A Versatile Drug Delivery System.” International Journal of Research in Pharmacy and Life Science, 2013; 4(8): 2920-2925.
9. Waghmare SG, Nikhade RR, Satish D, et al. Nanosponges: a novel approach for controlled release drug delivery system. International Journal of Pharmacy and Pharmaceutical Research. 2017;9(3):101-11.
10. Nilesh J., Ruchi J., Navneet T, Brham Prakash G., Deepak Kumar J., Nanotechnology: A Safe and Effective Drug Delivery Systems, Asian Journal of Pharmaceutical and Clinical Research, 2010 vol.3 issue 3 ,159-165.
11. Nacht S, Kantz M.; (1992) The microsponge: a novel topical programmable delivery system, In: Topical Drug Delivery Systems, David W.O and Anfon H.A (ED), 42.
12. Delattre L., Delneuville I., Biopharmaceutical aspects of the formulation of dermatological vehicles. J Eur Acad Derm Vener, 1995, 5: S70.
13. http://Sciencematters, Unimelb.edu.au/ 2011/05/nanosponges for targeted- cancer-treatment/visited on 12/10/2011.
14. Kaur G., Agrawal G., “Nanosponges: New Colloidal Drug Delivery System for Topical Delivery,”, 2015; 5(1): 53-57.
15. Kamal S., SarabjeetS., Ajay A., Sanju N., “Transdermal Gel: An Alternative Vehicle for Drug Delivery.” International Journal of Pharmaceutical Chemicals and Biological Science, 2013; 3(3): 495-503.
16. Behera A., Barik B., “Formulation and Evaluation of Isoniazide Loaded–Ʃ Poly caprolactone Nanoparticle.” Journal of Pharmacy Research.
17. 17.Eki S, Lei T, Jingquan L, Zhongfan J, Cyrille B, Thomas PD. Biodegradable star polymers functionalized with cyclodextrin inclusion complexes. Biomacromolecule 2009; 10:2699-707.
18. Prathima, S., Sreeja K. Formulation and Evaluation of Voriconazole Loaded Nanosponges for Oral and Topical Delivery. Int. J. Drug Dev. & Res., 2013; 5(1): 55-69.
19. Jyoti Pandey, Amandeep Singh. Formulation and Evaluation of Nanosponge Based Controlled Release Topical Gel Preparation of Ketoconazole. IJPPR., 2018;12(3).
20. Quarat-ul-ainshoaib, Nasir Abbas, Muhammad Irfan, Amjad Hussain, Muhammad Sohail Arshad, Syed Zajif Hussain, Sumera Latif, Nadeem Irfan Bukhari. Tropical Journal of Pharmaceutical Research., 2018;17(8):1465-1474.
21. P., Suresh Kumar, N., Hematheerthani, J., VijayaRatna, V., Saikishore. Preparation and Evaluation of Clotrimazole Loaded Nanosponges Containing Vaginal Gels. American journal of pharmacy and health research. American Journal of Pharmacy and Health Research., 2015; 3(7).
22. Swarupa Arvapally, M., Harini, G., Harshitha, A., Arunkumar. American Journal of Pharmtech Research. 2017; 7(3):2249-3387.
23. Nasir Abbas, Amjad Hussain, Muhammad Ahsan Hafiz, Kausar Perveen. British Journal of Pharmacy.,2017; 2(2):41-42.
24. Renuka Sharma, Roderick, B., Walker, Kamla Pathak. Evaluation of Kinetics and Mechanism of Drug Release from Econazole nitrate Nanosponge Loaded Carbopol Hydrogel. Ind J Pham Edu Res., 2011;45(1):25-31.
25. Shankar, S., Vavia, PR., Francesco T, Satyen T. Formulation of Betacyclodextrin based nanosponges of Itraconazole. J Incl Phenom Macrocycl Chem.,2007; 57(1):89-94.
26. Prathima, S., Sreeja K. Formulation and Evaluation of Voriconazole Loaded Nanosponges for Oral and Topical Delivery. Int. J. Drug Dev. & Res., 2013; 5(1): 55-69.
27. P., Suresh Kumar, N., Hematheerthani, J., VijayaRatna, V., Saikishore. Preparation and Evaluation of Clotrimazole Loaded Nanosponges Containing Vaginal Gels. American journal of pharmacy and health research. American Journal of Pharmacy and Health Research., 2015; 3(7).
28. Kumar, PS., Hematheerthani, N., VijayaRatna, J., Saikishore, V. Design and characterization of Miconazole nitrate loaded nanosponges containing vaginal gels. Int J Pharm Ana Res., 2016; 5(3):410-417.
29. Jyoti Pandey, Amandeep Singh. Formulation and Evaluation of Nanosponge Based Controlled Release Topical Gel Preparation of Ketoconazole. IJPPR., 2018;12(3).
30. Nasir Abbas, Amjad Hussain, Muhammad Ahsan Hafiz, Kausar Perveen. British Journal of Pharmacy., 2017; 2(2):41-42.
31. William, K., Benjamin, S., Eva, H. Synthesis and Characterization of Nanosponges for Drug Delivery and Cancer Treatment. Vanderbilt Education., 2011; 20(21).
32. Lala, R., Thorat, A., Gargote, C. Current trends in ß- cyclodextrin based drug delivery systems. Int J Res Ayur Pharm; 2011; 2(5): 1520-1526.
33. Subhash Chandra Bose Penjuri, Nagaraju Ravouru, Saritha Damineni, Sai Lakshmi Bns, Srikanth Reddy Poreddy. Formulation and Evaluation of Lansoprazole Loaded Nanosponges. Turk J Pharm Sci., 2016; 13(3): 304-310.
34. Torne, SJ., Ansari, KA., Vavia, PR., Trotta, F., Cavalli, R. Enhanced oral Paclitaxel bioavailability after administration of Paclitaxel loaded nanosponges. Drug Delivery., 2010; 17(6):419- 425.
35. Nanosponges; a boon to the targeted drug delivery system from SlideShare.
36. Patel, SB., Patel, HJ., Seth, AK. Nanosponge Drug Delivery System: An Overview. Journal of Global Pharma Tech., 2010;2(8):1- 9.
37. Anjali Kumar, Sheri, P.S., M.A., Kuriachan. Formulation and Evaluation of Antifungal Nanosponge Loaded Hydrogel for Topical Delivery. IJPPR., 2018;3(1).
38. Swaminathan, S., Vavia, P.R., Trotta. F: Formulation of beta cyclodextrins based nanosponges of itraconazole. J InclPhenom Macro Chem., 2012;57:89-94.
39. Nacht, S., Kantz, M. The Microsponge: A Novel Topical Programmable Delivery System In: Topical Drug Delivery Systems. New York: Marcel., 1992;42:299-325.
40. Cavalli, R., Ansari, K.A., Vavia, P.R. Nanosponges formulations as oxygen delivery systems. International journal of pharmaceutics.,2010;402:254-247.
41. Shewarts, D., Sofia, S., Friess, W. Integrity and stability studies of precipitated rhBMP-2 microparticles with a focus on ATR-FTIR measurements. Eur J Pharm Biopharm., 2006;63:241-248.
42. Gerges. et al. In vitro release modulation and conformational stabilization of a model protein using swellable polyamidoamine nanosponges of β-cyclodextrin. The Journal of Inclusion Phenomena and Macrocyclic Chemistry., 2010; 68: 183-191.
43. Khalid, AA., Pradeep, RV., Francesco, T., Roberta, C. Cyclodextrin-based nanosponges for delivery of Resveratrol: In Vitro characterisation, stability, cytotoxicity and permeation Study. Pharm Sci Tech., 2011; 12(1): 279-286.
Published
2023-08-13
How to Cite
Poonam, R., Prakash, J., Priyanka, S., Vivekkumar, R., Nikita, B., & Varda, J. (2023). A Comprehensive Review on Transdermal Delivery of Nanosponges. Asian Journal of Pharmaceutical Research and Development, 11(4), 126–128. https://doi.org/10.22270/ajprd.v11i4.1298
Issue
Section
Review Articles
AUTHORS WHO PUBLISH WITH THIS JOURNAL AGREE TO THE FOLLOWING TERMS:
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 Unported License. that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
.